Immunomodulating agent Galavit for the prevention of frequent acute respiratory viral infections after COVID-19: A review
Many convalescents of the new coronavirus infection caused by the SARS-CoV-2 virus, including mild and moderate severity, have frequent acute respiratory viral infections (ARVI) and other diseases of the ENT organs during the first 6 months after recovery. A well-known problem of COVID-19 is immune...
Sábháilte in:
Príomhchruthaitheoir: | |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
ZAO "Consilium Medicum",
2023-06-01T00:00:00Z.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Ar líne
Connect to this object online.3rd Floor Main Library
Gairmuimhir: |
A1234.567 |
---|---|
Cóip 1 | Ar fáil |